clinical trial · NCT01990040
Registry for Participants With Short Bowel Syndrome
Shire·—·active not recruiting·n = 1,806
Short Bowel Syndrome
brief summary
This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.
started
Jun 23, 2014
primary completion
Jun 30, 2032
completion
Jun 30, 2032
last updated
Oct 10, 2025
official title
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol